Abiopharma

🔍 MATHENY DRUE (Executive)

Company: DILLARD'S, INC. (DDS)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 10 shares of Common Class A at $638.19 per share (Direct)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 404,166.00 | transaction_form_type: 4
• Holds 0 shares of Common Class A - Retirement Plan (Direct)
  Date: 2026-08-24 | Code: H | shares_owned_after: 35,539.00
• Holds 0 shares of Common Class A (Direct)
  Date: 2026-08-24 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 7,300.00 | Footnotes: F1
• Holds 0 shares of Common Class A (Direct)
  Date: 2026-08-24 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 3,521.00 | Footnotes: F2
• Holds 273,724 shares of Common Class B (Derivative)
  Date: 2026-08-24 | Code: H | shares_owned_after: 273,724.00 | Footnotes: F3, F3, F3

Footnotes:

• F1: The amount reported represents shares of Issuer Class A Common Stock held by a trust for which the reporting person serves as trustee.
• F2: The amount reported represents shares of Issuer Class A Common Stock held by the reporting person's spouse.
• F3: Shares of Issuer Class B Common Stock are convertible at the option of any holder thereof into shares of Issuer Class A Common Stock on a one-for-one basis. Issuer Class B Common Stock has no expiration date.